Trade GOVX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
GeoVax Labs, Inc. (GOVX) is trading at US$0.37, up 2.27% today as of Sep 21, 11:43 EDT. The company has a market capitalisation of US$3.36M. Over the past 52 weeks, GOVX has traded between US$0.36 and US$17.50. On Syfe you can trade GOVX with $0 commission and add it to your watchlist.
| Previous close | US$0.36 |
|---|---|
| Market cap | US$3.36M |
| 52-week range | US$0.36 – US$17.50 |
| Volume | 221.08K |
| Exchange | US |
Add to Watchlist
Set Price Alert
GeoVax Labs, Inc.
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Year: 1995
GeoVax Labs, Inc. (GOVX) stock is trading at US$0.37, +2.27% from the previous close of US$0.36.
The market cap for GeoVax Labs, Inc. (GOVX) stock is approximately US$3.36M.
The 52-week high for GeoVax Labs, Inc. (GOVX) stock is US$17.50.
The 52-week low for GeoVax Labs, Inc. (GOVX) stock is US$0.36.
GeoVax Labs, Inc. (GOVX) does not currently pay a dividend.
Stay on top of GOVX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
